Author: Ravi Shankar

VANCOUVER, British Columbia, Sept. 23, 2026 (GLOBE NEWSWIRE) — SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC Energy” or the “Company”) is pleased to announce the voting results from its annual general meeting of shareholders held on September 18, 2026 (the “Meeting“).

Annual General Meeting Results

A total of 21,347,237 common shares of the Company were voted at the Meeting, in person or by proxy, representing 12.93% of the Company’s issued and outstanding common shares. The Chairperson confirmed that a quorum was present and that the Meeting was properly constituted for the transaction of business.

Shareholders approved all matters put before the Meeting, as follows:

• Shane Dungey, Michael Albertson, Felix (Fred) Andriano, Peter Busby, Dermot Sweeny and Kevin Hydes were each elected as directors of the Company to hold office until the next annual meeting of shareholders.
• Davidson & Company LLP was appointed as auditor of the Company for the ensuing year.

About SHARC Energy

SHARC International Systems Inc. is a world leader in wastewater based thermal energy transfer. SHARC Energy’s systems exchange thermal energy with wastewater, generating one of the most energy-efficient and economical systems for heating, cooling & hot water production for commercial, residential and industrial buildings along with thermal energy networks, commonly referred to as “District Energy”. SHARC Energy is publicly traded in Canada (CSE: SHRC), the United States (OTCQB: INTWF) and Germany (Frankfurt: IWIA) and you can find out more on our SEDAR profile.

ON BEHALF OF THE BOARD

Fred Andriano
Chairman

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

CONTACT: For investor inquiries, please contact:
Shane Dungey
Chief Executive Officer (SHARC Energy)
Telephone: 403.389.9911
Email: shane.dungey@sharcenergy.com

For media inquiries, please contact:
John Louis Fahie
Marketing (SHARC Energy)
Telephone: 604.475.7710 Ext.109
Email: johnlouis.fahie@sharcenergy.com

CALGARY, Alberta, Sept. 23, 2026 (GLOBE NEWSWIRE) — Global Uranium Corp. (CSE: GURN | OTC: GURFF | FRA: Q3J0) (the “Company“) is pleased to announce that it intends to complete a non-brokered private placement financing under the Listed Issuer Financing Exemption (the “LIFE Offering”) for minimum gross proceeds of $450,000 and maximum gross proceeds of $932,736.

The LIFE Offering will consist of a minimum of 2,045,455 units and a maximum of 4,239,711 units of the Company (each, a “Unit”) at a price of $0.22 per Unit. Each Unit will consist of one common share in the capital of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”).

Each Warrant will entitle the holder to acquire one additional Common Share at an exercise price of $0.30 per Common Share, commencing on the date that is 61 days following the closing of the LIFE Offering (the “Closing”) and ending 24 months following the Closing.

The Company intends to use the available funds from the LIFE Offering, together with its existing working capital, primarily for exploration expenditures relating to the Astro Uranium Project and the Company’s uranium projects in Wyoming, general and administrative expenditures and general working capital purposes.

The LIFE Offering is expected to close on or about October 16, 2026, or such other date or dates as the Company may determine, and may close in one or more tranches. The LIFE Offering is subject to the approval of the Canadian Securities Exchange. The Company has not engaged any dealers or finders in connection with the LIFE Offering, and no commissions, finder’s fees or finder’s warrants will be paid or issued in connection with the LIFE Offering.

The LIFE Offering is being completed pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 – Prospectus Exemptions, as modified by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption, and is being made to purchasers resident in all provinces of Canada, except Quebec and New Brunswick. The securities issued pursuant to the LIFE Offering are expected to be immediately freely tradeable under applicable Canadian securities legislation.

There is an offering document related to the LIFE Offering that can be accessed under the Company’s profile at SEDAR+ and on the Company’s website. Prospective investors should read this offering document before making an investment decision.

The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any United States state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or any available exemption from the registration requirements of the U.S. Securities Act and applicable United States state securities laws. This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

About Global Uranium Corp.

Global Uranium Corp. is an exploration-stage company focused on exploring and developing uranium assets primarily in North America. The Company currently has rights to the Wing Lake Property in the Mudjatik Domain of northern Saskatchewan, the Astro Uranium Project in the eastern Athabasca Basin, Saskatchewan, and uranium projects located in the Great Divide Basin, Gas Hills and Copper Mountain districts of Wyoming, USA.

On Behalf of the Board of Directors

Ungad Chadda
CEO and Director

587-330-0045
info@globaluranium.com

Forward-Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian securities legislation. Forward-looking information in this news release includes statements regarding the completion and timing of the LIFE Offering, the issuance of the Units, Common Shares and Warrants, the intended use of available funds, and the receipt of approval of the Canadian Securities Exchange. Forward-looking information is based on assumptions considered reasonable by management as of the date hereof and is subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those anticipated. Readers are cautioned not to place undue reliance on forward-looking information. The Company undertakes no obligation to update forward-looking information except as required by applicable securities laws.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release.

Industry’s First End-to-End Flow Cytometry Platform Covering Panel Design Through Data Analysis

FREMONT, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) — Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the expansion of its Cytek^® Cloud digital ecosystem with a new Cloud Analysis tool, establishing the industry’s first end-to-end platform that integrates the entire flow cytometry workflow from panel design to data analysis into one system. Cytek Cloud is built by the scientists and engineers behind Cytek Full Spectrum Profiling™ (FSP^®) technology and gives researchers a consistent experience from experiment planning through data analysis while reducing the need to move between systems or recreate work along the way.

Historically, moving from data acquisition to analysis has meant transferring data to a separate platform and recreating worksheets, plots and gates. Cytek’s Cloud Analysis tool changes that workflow by preserving experimental data and allowing researchers to import it directly from SpectroFlo^® desktop software, so they can pick up their analysis where they left off. The cloud-based environment also provides online data storage, giving researchers access to their data and analysis workflows from virtually anywhere, on a Mac or PC.

With more than 28,000 users and double-digit year-over-year user growth, Cytek Cloud has solidified its place as a crucial resource for researchers since its introduction in 2022. The platform supports full spectrum flow cytometry research from panel design and experiment setup through data acquisition and now data analysis.

The Cytek Cloud Digital Ecosystem
Cytek Cloud currently includes a suite of integrated online tools, including Full Spectrum Viewer, Panel Builder, Experiment Builder and Cloud Analysis, designed to support workflows on Cytek Northern Lights™, Cytek Aurora^®, Cytek Aurora^® Evo and Cytek Aurora^® CS systems. Panel Builder helps researchers design spectral panels while taking into account factors such as antigen density, marker expression and reagent availability. Researchers can search and work from pre-designed panels and Optimized Multicolor Immunofluorescence Panels (OMIPs), as well as build and share their own panels.

Cytek Cloud also features the AI-powered SpectroPanel™ tool, which uses machine learning to automate the assignment of fluorochromes to selected markers. Researchers provide biological information for their experiment, and SpectroPanel can generate an optimized panel in less than a minute – a process that could otherwise take hours, days or longer depending on the complexity of the experiment and the user’s experience. The tool also provides reagent information and integrates with Cytek’s reagent catalog and select partner catalogs, enabling researchers to order the reagents needed for their experiments directly through Cytek Cloud.

Additionally, Cytek is introducing the Cytek Cloud Premium license, a new subscription tier that includes all the capabilities of the Pro license, plus cloud-based data analysis and online storage. Cytek Cloud will now offer three subscription plans designed to meet different research needs:

• Cytek Cloud Basic: Provides access to the core Cytek Cloud tools at no cost.
• Cytek Cloud Pro: Adds advanced capabilities, including the SpectroPanel algorithm and Experiment Builder features.
• Cytek Cloud Premium: Includes all Pro capabilities, along with Cloud Analysis and online data storage; this is currently available for customers in the U.S. only.

Recognized as a pioneer in spectral flow cytometry, Cytek’s distinctive approach is renowned for its influence on advancing the understanding of cell biology, immunology, oncology and targeted therapeutic methodologies.

“Researchers should be able to move seamlessly from experiment design and data acquisition to analysis without having to switch between systems or disrupt their workflow,” said Wenbin Jiang, Ph.D., CEO of Cytek Biosciences. “By bringing powerful analysis capabilities into Cytek Cloud, we are creating a more connected experience that helps researchers get from data to insight more efficiently. This expansion is an important milestone in our vision for Cytek Cloud as a comprehensive digital ecosystem that supports the flow cytometry workflow from beginning to end.”

The new Cloud Analysis tool for Cytek Cloud is currently available in the U.S. For more information, please visit https://cytekbio.com/pages/cytek-cloud.

About Cytek Biosciences, Inc.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling™ (FSP^®) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s platform includes: its core FSP instruments, the Cytek Aurora^®, Northern Lights™, Cytek Aurora^® CS and Cytek Aurora^® Evo systems; the Muse^® Micro system; the Cytek Orion™ reagent cocktail preparation system; the Enhanced Small Particle™ (ESP™) detection technology; the flow cytometers and imaging products under the Amnis^® and Guava^® brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.

Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use only in China and the European Union).

Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Cytek Borealis, Northern Lights, Enhanced Small Particle, ESP, Cytek Orion, Muse, Amnis and Guava are trademarks or registered trademarks of Cytek Biosciences, Inc.

In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections. All statements other than statements of historical facts are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. These forward-looking statements include, but are not limited to, statements regarding Cytek’s business strategies, market opportunities, product plans and expectations, including with respect to Cytek Cloud and its capabilities. These statements are based on management’s current expectations, forecasts, beliefs, assumptions and information currently available to management. These statements also deal with future events and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, Cytek’s ability to successfully develop and introduce new products; global geopolitical, economic and market conditions; and other risks discussed in the section titled “Risk Factors” set forth in Cytek’s Quarterly Report on Form 10-Q filed on August 5, 2026 with the SEC and other filings Cytek makes with the SEC from time to time, which contain a discussion of important factors that may cause actual results to differ materially from those expressed or implied by Cytek’s forward-looking statements. Although Cytek believes that the expectations reflected in the forward-looking statements are reasonable, it cannot provide any assurance that these expectations will prove to be correct nor can it guarantee that the future results, levels of activity, performance, and events and circumstances reflected in the forward-looking statements will be achieved or occur. The forward-looking statements in this press release are based on information available to Cytek as of the date hereof, and Cytek disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing Cytek’s views as of any date subsequent to the date of this press release.

Media Contact:
Stephanie Olsen
Lages & Associates
(949) 453-8080
stephanie@lages.com

Investor Contact:
Mark Meehan
Senior Director, Head of Investor Relations
Cytek Biosciences
mmeehan@cytekbio.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4bc99405-4fa5-4f99-a538-cab508c7da71

Not for distribution to U.S. newswire services or for dissemination in the United States.

CALGARY, Alberta, Sept. 23, 2026 (GLOBE NEWSWIRE) — Northview Residential REIT (the “REIT”) today announced its September 2026 cash distribution amounts on its outstanding Class A Units, Class C Units and Class F Units (collectively, the “Units”) in the amount of C$0.091146 per Unit (C$1.09 per Unit on an annualized basis). The distribution will be payable on October 15, 2026 to holders of Units of record at September 30, 2026.

About Northview Residential REIT

The REIT is a publicly traded real estate investment trust established pursuant to a declaration of trust under the laws of the Province of Ontario for the primary purpose of indirectly acquiring, owning and operating a portfolio of income producing rental properties in secondary markets within Canada.

To learn more about the REIT, visit www.rentnorthview.com or contact:

Todd Cook, President and Chief Executive Officer
Northview Residential REIT
Tel:	(403) 531-0720
Email:	tcook@nvreit.ca
Sarah Walker, Chief Financial Officer
Northview Residential REIT
Tel:	(403) 531-0720
Email:	swalker@nvreit.ca

MONTREAL, Sept. 23, 2026 (GLOBE NEWSWIRE) — D-BOX Technologies Inc. (“D-BOX” or the “Corporation”) (TSX: DBO) held its annual meeting of shareholders today (the “Meeting”). A total of 97,464,238 Class A common shares of the Corporation (representing approximately 43.87% of the issued and outstanding Class A common shares of the Corporation as of the record date) were represented at the Meeting. D-BOX announces that shareholders of the Corporation voted in favour of all items of business put forth at the Meeting by the Corporation. The complete voting results for each item of business at the Meeting are presented below.

ELECTION OF DIRECTORS

All of the proposed nominees for the Board of Directors in the proxy circular dated August 11, 2026 were elected at the Meeting.

NAME OF NOMINEE	VOTES FOR	% FOR	VOTES AGAINST	% AGAINST
Naveen Prasad	78,846,076	99.97%	26,392	0.03%
Brigitte Bourque	78,846,076	99.97%	26,392	0.03%
Daniel Marks	78,816,016	99.93%	56,452	0.07%
Dave McLurg	78,084,849	99.00%	787,619	1.00%
Lori Tersigni	78,844,981	99.97%	27,487	0.03%

At a meeting of the Board of Directors held immediately following the Meeting, the Board re-appointed Dave McLurg, an independent director, as Chair of the Board.

APPOINTMENT OF INDEPENDENT AUDITORS

Ernst & Young LLP were appointed as independent auditors of the Corporation until the close of the next annual meeting of shareholders, or until their successor is appointed, and the Directors were authorized to fix their remuneration.

VOTES FOR	% FOR		VOTES WITHHELD	% WITHHELD
96,561,858	99.07%		902,380	0.93%

ABOUT D-BOX

D-BOX Technologies Inc. (TSX: DBO) is a global leader in haptic technology, delivering immersive motion experiences that engage the body and spark the imagination. D-BOX’s patented systems synchronize motion, vibration, and texture with on-screen content, enhancing storytelling across various platforms. With over 25 years of innovation, D-BOX’s solutions are used in movie theaters, sim racing, and simulation & training. Headquartered in Montreal, Canada, with offices in Los Angeles, USA, D-BOX continues to redefine how audiences experience media worldwide. Visit https://www.d-box.com/.

FOR FURTHER INFORMATION, PLEASE CONTACT:

D-BOX Media Relations
media@d-box.com

(All dollar amounts are expressed in U.S. dollars, unless otherwise noted.)

TORONTO, Sept. 23, 2026 (GLOBE NEWSWIRE) — Kinross Gold Corporation (TSX: K; NYSE: KGC) (“Kinross” or the “Company”) today provided an operational, guidance and return of capital update. The Company now expects full-year 2026 and 2027 attributable production to be 2% to 3% below the low end of the previously disclosed guidance, with approximately 1.84 to 1.86 million gold equivalent ounces (“Au eq. oz.”) expected per year. The change to the Company’s 2026 guidance is concentrated at two smaller assets, La Coipa and Round Mountain, and is the result of extreme weather and operational challenges. The balance of the portfolio continues to perform well, led by Paracatu and Tasiast, the Company’s two largest, lowest-cost operations. Kinross expects third-quarter 2026 attributable production of approximately 425,000 Au eq. oz¹.

Adjusting the Company’s 2026 cost guidance as a result of the updated production estimates, attributable production cost of sales^{1, 2} is expected to be approximately $1,420 to $1,460 per Au eq. oz. sold and attributable all-in sustaining cost^{1, 2} is expected to be approximately $1,850 to $1,900 per Au eq. oz. sold. Total operating and capital costs for the year remain on track despite higher oil prices.

Reflecting its strong cash flow outlook and balance sheet strength, Kinross is increasing its return of capital target from 40% to 50% of free cash flow to shareholders for 2026.

La Coipa, Chile

At La Coipa, a series of unprecedented winter weather events throughout the third quarter disrupted mining and milling activities. Continuing weather impacts have resulted in lower than planned mining rates and mill throughput into September.

The Company also saw higher than expected copper grades and lower than expected recoveries in some of the sulphide ore mined at La Coipa in the third quarter and has adjusted the production forecast for 2026 and 2027 to reflect lower recovery and stockpiling of some high copper material for potential future processing.

While the La Coipa mine plan includes processing of some higher copper sulphide ore blended with oxide ore through the existing circuit, a pre-feasibility study is underway to study the potential for the addition of a flotation circuit focused on the higher copper sulphide mineralization identified below multiple open pit mines at La Coipa. This transition from oxide to higher copper sulphide mineralization across multiple deposits in close proximity is also indicative of the potential for an underlying copper porphyry system, for which Kinross is actively exploring.

Weather and mining conditions have begun to stabilize, improving mining rates and the ability to blend, and the site is implementing a variety of measures to improve plant throughput and recovery with recent positive results.

_______________
1 Unless otherwise stated, production figures in this news release are on an attributable basis. “Attributable” includes Kinross’ 70% share of Manh Choh production, costs and capital expenditures. Financial figures include 100% of Manh Choh results except when denoted as attributable. Attributable production, attributable cost of sales and attributable all-in sustaining cost figures are non-GAAP financial measures and ratios and have no standardized meaning under International Financial Reporting Standards and therefore, may not be comparable to similar measures presented by other issuers. Please see the Company’s most recently filed Management’s Discussion and Analysis section 11 for a reconciliation of the Company’s attributable production cost of sales per Au eq. oz. sold and attributable all-in sustaining cost per Au eq. oz. sold to their related GAAP ratios.
2 Assumptions used to update the Company’s cost guidance include a gold price of $4,350 per ounce, an oil price of $100 per barrel, and foreign exchange rates of 5.10 Brazilian reais, 920 Chilean pesos, and 40 Mauritanian ouguiyas to the U.S. dollar for the remainder of 2026.

Round Mountain, United States

At Round Mountain Phase S, lower mining rates and lower than expected grades and recoveries have reduced annual production expectations in 2026 and 2027. The lower mining rates result in a deferral of higher-grade Phase S ore into future periods, while the lower mill grade and recoveries result in a loss of production versus prior estimates. The operation is focused on implementing initiatives to improve the mill grade, recovery and mining rates.

Phase S is being mined as a bridge to longer-term operations at Phase X underground. Grades, recoveries and production are expected to improve as the Phase X underground ramps up and higher-grade ore is blended with Phase S ore. The Company has recently seen positive results from infill drilling at Phase X indicating higher ounces than expected in the early stoping horizons. Phase X remains on track and is expected to contribute production as planned in 2028.

Portfolio performance

Paracatu and Tasiast, the Company’s two largest, lowest-cost operations, continue to deliver strong performance and are expected to produce a combined 1.1 million ounces for the fifth consecutive year, in line with previously disclosed guidance, supporting significant free cash flow generation. The revised 2026 and 2027 outlook is concentrated at La Coipa and Round Mountain and does not change the quality of the Company’s broader portfolio or its ability to generate strong cash flow.

Kinross continues to advance its pipeline of development projects on schedule, including its U.S. projects, Great Bear and Lobo-Marte while maintaining a strong balance sheet and its disciplined approach to capital allocation. In 2028, Kinross expects to benefit from the commencement of production at Phase X and Curlew, while Tasiast advances into the higher-grade portion of the orebody at the bottom of the open pit. Together, these opportunities support the Company’s delivery of sustainable, long-term value through the execution of its grade enhancement strategy.

Increasing shareholder returns

The Company also continues to return meaningful capital to shareholders through share buybacks and dividends. Reflecting its strong cash flow outlook and balance sheet strength, Kinross is increasing its return of capital target by 25%, from 40% to 50%, of free cash flow for 2026, reinforcing the Company’s commitment to returning capital to shareholders. To date in 2026, Kinross has returned approximately $800 million to shareholders, including approximately $655 million in share repurchases. Since the first quarter of 2025, Kinross has returned more than $1.5 billion to shareholders and has repurchased more than 4% of its outstanding shares.

About Kinross Gold Corporation

Kinross is a Canadian-based global senior gold mining company with operations and projects in the United States, Brazil, Mauritania, Chile and Canada. Our focus is on delivering value based on the core principles of responsible mining, operational excellence, disciplined growth, and balance sheet strength. Kinross maintains listings on the Toronto Stock Exchange (symbol: K) and the New York Stock Exchange (symbol: KGC).

Media Contact
Samantha Sheffield
Senior Director, Corporate Communications
phone: 416-365-3034
Samantha.Sheffield@Kinross.com

Investor Relations Contact
David Shaver
Executive Vice-President, Investor Relations & Communications
phone: 416-365-2854
InvestorRelations@Kinross.com  

Cautionary statement on forward-looking information

All statements, other than statements of historical fact, contained or incorporated by reference in this news release including, but not limited to, any information as to the future financial or operating performance of Kinross, constitute “forward-looking information” or “forward-looking statements” within the meaning of certain securities laws, including the provisions of the Securities Act (Ontario) and the provisions for “safe harbor” under the United States Private Securities Litigation Reform Act of 1995 and are based on expectations, estimates and projections as of the date of this news release. Forward-looking statements contained in this news release, include, but are not limited to: statements with respect to our guidance for production and cost of sales, including attributable production costs of sales, attributable all-in sustaining cost of sales, and total costs; anticipated returns of capital to shareholders, including the Company’s statement targeting share buybacks for 2026 of 50% of free cash flow; the Company’s liquidity; the Company’s expectations regarding mining, milling and recoveries and its ability to mitigate ongoing operational and recovery issues at La Coipa and Round Mountain and the Company’s ability to advance its pipeline of development projects on schedule. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by Kinross as of the date of such statements, are inherently subject to significant business, economic and competitive uncertainties and contingencies. The estimates, models and assumptions of Kinross referenced, contained or incorporated by reference in this news release, which may prove to be incorrect, include, but are not limited to, the various assumptions set forth herein and in our Management’s Discussion and Analysis (“MD&A”) for the year ended December 31, 2025, and the Annual Information Form dated March 26, 2026 as well as: there being no significant disruptions affecting the operations of the Company, whether due to extreme weather events and other or related natural disasters, labour disruptions (including but not limited to strikes or workforce reductions), supply disruptions, power disruptions, damage to equipment, pit wall slides or otherwise; the effectiveness of mitigation and remediation efforts targeting ongoing operational and recovery issues meeting the Company’s expectations; and the Company’s financial results, cash flows and future prospects being consistent with Company expectations in amounts sufficient to permit sustained returns of capital. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements. Such factors include, but are not limited to: the inaccuracy of any of the foregoing assumptions; fluctuations in the currency markets; fluctuations in the spot and forward price of gold or certain other commodities (such as fuel and electricity); price inflation of goods and services; changes in the discount rates applied to calculate the present value of net future cash flows based on country-specific real weighted average cost of capital; changes in the market valuations of peer group gold producers and the Company, and the resulting impact on market price to net asset value multiples; changes in various market variables, such as interest rates, foreign exchange rates, gold or silver prices and lease rates, or global fuel prices, that could impact the mark-to-market value of outstanding derivative instruments and ongoing payments/receipts under any financial obligations; risks arising from holding derivative instruments (such as credit risk, market liquidity risk and mark-to-market risk); changes in national and local government legislation, taxation (including but not limited to income tax, advance income tax, stamp tax, withholding tax, capital tax, tariffs, value-added or sales tax, capital outflow tax, capital gains tax, windfall or windfall profits tax, production royalties, excise tax, customs/import or export taxes/duties, asset taxes, asset transfer tax, property use or other real estate tax, together with any related fine, penalty, surcharge, or interest imposed in connection with such taxes), controls, tariffs, policies and regulations; the security of personnel and assets; political or economic developments in Canada, the United States, Chile, Brazil, Mauritania or other countries in which Kinross does business or may carry on business; business opportunities that may be presented to, or pursued by, us; our ability to successfully integrate acquisitions and complete divestitures; operating or technical difficulties in connection with mining, development or refining activities; employee relations; litigation or other claims against, or regulatory investigations and/or any enforcement actions, administrative orders or sanctions in respect of the Company (and/or its directors, officers, or employees) including, but not limited to, securities class action litigation in Canada and/or the United States, environmental litigation or regulatory proceedings or any investigations, enforcement actions and/or sanctions under any applicable anti-corruption, international sanctions and/or anti-money laundering laws and regulations in Canada, the United States or any other applicable jurisdiction; the speculative nature of gold exploration and development including, but not limited to, the risks of obtaining and maintaining necessary licenses and permits; diminishing quantities or grades of reserves; adverse changes in our credit ratings; and contests over title to properties, particularly title to undeveloped properties. In addition, there are risks and hazards associated with the business of gold exploration, development and mining, including environmental hazards, industrial accidents, unusual or unexpected formations, pressures, cave-ins, flooding and gold bullion losses (and the risk of inadequate insurance, or the inability to obtain insurance, to cover these risks). Many of these uncertainties and contingencies can directly or indirectly affect, and could cause, Kinross’ actual results to differ materially from those expressed or implied in any forward-looking statements made by, or on behalf of, Kinross, including but not limited to resulting in an impairment charge on goodwill and/or assets. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. All of the forward-looking statements made in this news release are qualified by this cautionary statement and those made in our other filings with the securities regulators of Canada and the United States including, but not limited to, the cautionary statements made in the “Risk Analysis” section of our MD&A for the year ended December 31, 2025, and the “Risk Factors” set forth in the Company’s Annual Information Form dated March 26, 2026. These factors are not intended to represent a complete list of the factors that could affect Kinross. Kinross disclaims any intention or obligation to update or revise any forward-looking statements or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law.

Key Sensitivities

Approximately 70%-80% of the Company’s costs are denominated in U.S. dollars.

A 10% change in foreign currency exchange rates would be expected to result in an approximate $30 impact on attributable production cost of sales per equivalent ounce sold^{1, 3}.

Specific to the Brazilian real, a 10% change in the exchange rate would be expected to result in an approximate $50 impact on Brazilian attributable production cost of sales per equivalent ounce sold¹.

Specific to the Chilean peso, a 10% change in the exchange rate would be expected to result in an approximate $60 impact on Chilean attributable production cost of sales per equivalent ounce sold¹.

A $10 per barrel change in the price of oil would be expected to result in an approximate $10 impact on attributable production cost of sales per equivalent ounce sold¹.

A $100 change in the price of gold would be expected to result in an approximate $5 impact on attributable production cost of sales per equivalent ounce sold¹ as a result of a change in royalties.

_______________
3 Refers to all of the currencies in the countries where the Company has mining operations, fluctuating simultaneously by 10% in the same direction, either appreciating or depreciating, taking into consideration the impact of hedging and the weighting of each currency within our consolidated cost structure.

Source: Kinross Gold Corporation

TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2026 Aide Memoire is available on the “Investors” page on its website.

Q3 2026 Aide Memoire

Teva has compiled this document with public information that was previously provided by Teva in order to assist investors ahead of third quarter 2026 results, which are expected to be released on Tuesday, November 3, 2026, at 7:00 a.m. ET, followed by a conference call at 8:00 a.m. ET on the same day. This document is based on Teva’s prior results, management’s previous commentary about Teva’s business outlook and data from select independent sources.

About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements
This press release and the Aide Memoire document may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in this press release, and in our Quarterly Report on Form 10-Q for the second quarter of 2026, and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned “Risk Factors” and “Forward-Looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Teva Media Inquiries
TevaCommunicationsNorthAmerica@tevapharm.com

Teva Investor Relations Inquiries
TevaIR@Tevapharm.com

TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2026 financial results on Tuesday, November 3, 2026, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET.

In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin.

A live webcast of the call will be available on Teva’s website at: https://ir.tevapharm.com/Events-and-Presentations.

Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva’s website.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements

This Document and the presentation at the conference call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. You can identify these forward-looking statements by the use of words such as “should,” “expect,” “anticipate,” “estimate,” “target,” “may,” “project,” “guidance,” “intend,” “plan,” “believe” and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace; our ability to successfully execute on our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and to profitably commercialize our innovative medicines and biosimilar portfolio, whether organically or through business development, to sustain and focus our portfolio of generic medicines, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the second quarter of 2026, and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned “Risk Factors” and “Forward Looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Teva Media Inquiries
TevaCommunicationsNorthAmerica@tevapharm.com

Teva Investor Relations Inquiries
TevaIR@Tevapharm.com

WINTER PARK, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company building the future of the commodity markets through tokenization, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29, 2026.

Company Webcast

The webcast presentation will take place at 3:30 p.m. ET on Tuesday, September 29, 2026. The webcast can be accessed by visiting the conference website at https://lythampartners.com/fall2026/ or directly at https://app.webinar.net/E2lpqML7me1. The webcast will also be available for replay following the event on the company’s website at https://ir.streamex.com/news-events/events.

1×1 Meetings

Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1×1@lythampartners.com or register for the event at https://lythampartners.com/fall2026invreg/.

About Streamex Corp.

Streamex Corp. (NASDAQ: STEX) is a technology and infrastructure company focused on the tokenization and digitalization of commodity real-world assets. Streamex delivers institutional-grade solutions that bridge traditional finance and blockchain-enabled markets through secure, regulated, and yield-bearing financial instruments.

For more information, visit www.streamex.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Streamex’s business strategy, product development, and participation in the Lytham Partners Fall 2026 Investor Conference. These statements are based on current expectations and assumptions subject to risks and uncertainties beyond Streamex’s control, and actual results may differ materially, including as a result of market conditions, regulatory developments, and macroeconomic factors affecting digital asset markets. A discussion of these and other factors is set forth in Streamex’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Streamex undertakes no obligation to update any forward-looking statements except as required by law.

Contacts

Laura Kiernan	Henry McPhie
Head of Investor Relations, Streamex Corp.	Chief Executive Officer, Streamex Corp.
IR@streamex.com | 1-914-598-7733	www.streamex.com | X.com/streamex

SYDNEY, Australia, Sept. 23, 2026 (GLOBE NEWSWIRE) — GMEX Robotics Corporation (Nasdaq: GMEX) (the “Company”), today announced that it will effect a share consolidation of all of its issued and unissued Class A ordinary shares, Class B ordinary shares and Class C ordinary shares, of US$0.8064 par value each, at a ratio of 1-for-9, effective on September 28, 2026 (the “Share Consolidation”). Immediately following Share Consolidation, the Company’s par value of all of its issued and unissued shares will be reduced to US$0.000001 per share (the “Reduction of Par Value”). The Share Consolidation and the Reduction of Par Value will apply to the Company’s Class A Ordinary Shares, Class B Ordinary Shares and Class C Ordinary Shares. Except for the changes expressly described in this announcement, the rights attaching to each of shares will remain unchanged.

The Company’s Class A ordinary shares are expected to begin trading on a post-consolidation and par value reduction basis at the open of the market session on September 28, 2026. Upon the market opening on September 28, 2026, the Company’s Class A ordinary shares will continue to be traded on The Nasdaq Capital Market under the symbol “GMEX” with the new CUSIP number G3514S161. This decision represents a deliberate capital structure optimization, aligning the Company’s market profile with its significant operational progress and ambitious future roadmap.

The Share Consolidation and Reduction of Par Value were approved by the Company’s board of directors on September 2, 2026. Pursuant to the BVI Business Companies Act (as amended) and the Company’s Memorandum and Articles of Association, the Company’s Board of Directors is authorized to effect the Share Consolidation without the approval of the Company’s shareholders. Accordingly, no shareholder vote, consent or approval is required or will be sought in respect of the Share Consolidation or the Reduction of Par Value.

As of September 17, 2026, there were 6,771,947 of the Company’s Class A ordinary shares outstanding and 799 Class B ordinary shares outstanding. Effecting the 1-for-9 Share Consolidation will reduce the outstanding Class A ordinary shares to 752,439 and the outstanding Class B ordinary shares to 89, subject to adjustment resulting from the treatment of fractional shares. There are no Class C ordinary shares outstanding as of September 17, 2026.

As a result of the Share Consolidation and Reduction of Par Value, the Company is authorised to issue a maximum of 1,407,472,426 shares of US$0.000001 par value each divided into: (i) 940,677,978 Class A ordinary shares of US$0.000001 par value each; (ii) 266,794,448 Class B ordinary shares of US$0.000001 par value each; and (iii) 200,000,000 Class C ordinary shares of US$0.000001 par value each, and the number of issued shares of the Company remains unchanged.

“We are building a company designed for scale, performance, and sustained value creation,” stated Sam Lu, Chief Executive Officer of GMEX Robotics Corporation. “Our strengthened equity profile provides greater flexibility and a more robust platform for future value-accretive initiatives. This positions us optimally to consider strategic partnerships, acquisitions, or other capital market activities from a position of strength”.

As a result of the Share Consolidation, every nine (9) issued and unissued shares of each class of the Company’s shares will be automatically consolidated into one (1) share of the same class.

Outstanding warrants and other outstanding equity rights will be proportionately adjusted to reflect the Share Consolidation. No fractional shares will be issued in connection with the Share Consolidation, and in the event that a shareholder would otherwise be entitled to receive a fractional share upon the Share Consolidation, the number of shares to be received by such shareholder will be rounded up to one ordinary share of the same class in lieu of the fractional share that would have resulted from the Share Consolidation. Shareholders who are holding their shares in electronic form at brokerage firms do not need to take any action, as the effect of the Share Consolidation will automatically be reflected in their brokerage accounts.

The Company’s transfer agent, Vstock Transfer LLC, which is also acting as the exchange agent for the Share Consolidation, will send instructions to shareholders of record who hold stock certificates regarding the exchange of their old certificates for new certificates, should they wish to do so. Shareholders who hold their shares in brokerage accounts or “street name” are not required to take action to implement the exchange of their shares.

About GMEX Robotics Corporation:

Formerly known as Fitell Corporation, GMEX Robotics Corporation is a technology company operating at the intersection of consumer health and advanced automation. Building on a foundation of fitness equipment e-commerce, the Company is expanding its mission to design and deliver AI-driven robotic solutions that prioritize genuine consumer needs.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this press release are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties, including market and other conditions, and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “could,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “propose,” “potential,” “continue” or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the Securities Exchange Commission.

Media Contact:
Jacqueline Grose
CORE IR & PR
Press@GMEXRobotics.com
(212) 655-0924
www.GMEXRobotics.com

Investor Contact:
CoreIR
IR@GMEXRobotics.com